US Coronavirus: FDA Approves Syringe that Can Remove an Excess Dose of Vaccine

Originally, each vial of Pfizer’s Kovid-19 vaccine was designed to contain five doses, but some pharmacists reported that they could extract six doses while using some syringes.

As a result, the FDA approved an updated label stating: “Low dead-volume syringes and / or needles may be used to extract six doses from one vial. If standard syringes and needles are used , Then there may not be enough. Remove the sixth dose from a vial. “

Pfizer CEO Albert Borla said that this increase per dose “provides an additional 20% capacity.” The New York Times first reported Pfizer’s plans to be based on dosage rather than vials.

However, CNN’s chief medical correspondent, Dr. Sanjay Gupta said that the ability to take a sixth dose with these syringes on Friday is not present everywhere.

“He has many places,” Gupta told CNN’s John Burman, “but not everywhere.”

McKesson, a medical supply company that the federal government has contracted to help with the delivery, said syringe kits that allow the withdrawal of the sixth dose.

These changes highlight the push to vaccinate as many people as possible amidst inconsistent supply chains.

According to CDC data, about 5% of the US population updated Friday – about 16.2 million people have received at least one dose of the vaccine, and 2.75 million people have been fully vaccinated. About 1.6 million vaccine doses were administered on Friday, the largest one-day increase reported.

New cases are down, but things remain serious

As inoculation efforts build, the epidemic continues unabated. While the analysis of CNN data promotes new daily cases and hospitalization trends, health authorities remain concerned about the more-variable version previously identified in the UK.

“You’re going to see people traveling again, perhaps for spring break in March and April,” said Dr. Biden, a former member of the Kovid-19 advisory board of transition. Said Celine Gounder. “And that’s exactly what we expect when these variants – in particular, the UK variants – have taken hold in the US.”

• Cases: Johns Hopkins University reported more than 186,000 new cases on Friday. The US currently averages 180,816 new daily cases over seven days. This is the lowest since December 2, and 27% below the peak seen on January 11, when the average of new cases hit 249.168 during a week. But the current average is still 2.7 times higher than the summer high in July.

• Hospitalization: As of Friday, there were 116,264 Kovid-19 patients in US hospitals, a metric that falls day-to-day according to data from the COVID Tracking Project. This is the lowest since December 21, but it is still nearly double that summer.

• Deaths: According to Johns Hopkins data, there were 3,655 new deaths on Friday. There are more than 3,000 new deaths a day in the US in a week.

‘It shouldn’t be a hunger game’

According to Michael Austerholm, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota, the lack of information and lack of financial support has left states struggling to manage a slow Kovid-19 vaccine rollout.

“I’m also eligible to get a vaccination in Minnesota and I can’t get one,” President Joe Biden’s former coronovirus consultant Osterholm told CNN’s Erin Burnett on Friday. “I want to share that frustration loudly and clearly.”

Utah Governor Spencer Cox told CNN’s Chris Cuomo that the state is well positioned for distribution, but that the vaccine allocation has been bottled at private pharmacies nationwide.

Local reporters are a lifeline to help readers find the vaccine

“Utah has long-term care facilities, they have too many vaccines. We estimate that they have 15 to 16,000 additional doses that they don’t need and they can’t use right now. So, we’re back to it. Taking and us. ” “Give it to our local health departments and it will be gone next week,” Cox said.

Disappointment over the delivery of vaccines and concerns over supply have erupted across the country.

Governor John Bel Edwards said on Friday that there is no vaccination site established in Louisiana because it does not have enough vaccines to manage a site.

New York State has administered 97% of its allotted first dose of the Kovid-19 vaccine, Gov. Andrew Andrew said on Friday, and hopes to pass out soon.

On Saturday, Cuomo spoke to a vaccine pop-up site in a public housing complex in Brooklyn, where he emphasized the importance of equal access to the vaccine for Black and Brown communities, which are prone to the epidemic.

“Wealthier, there was more Kovid testing in white communities,” he said. “When it comes to this vaccine, access across the board is appropriate.”

Studies show that 60% of Americans don or receive the -19 vaccine.
In Texas, the Houston Health Department’s 1,600 new vaccination appointment slots were filled by eligible citizens within about five minutes of opening. Sylvester Turner, the mayor of Houston, said the telephone system received about 250,000 calls, which literally “overwhelmed” the system.

Atlanta Mayor Keisha Lance Bottoms told CNN’s Wolf Blitzer that he receives daily calls from people “desperately seeking vaccines,” adding “I’m not just seeing an abundance of vaccines.”

The Los Angeles County Department of Public Health said Friday that currently only 1 in 4 eligible people is receiving adequate doses to be vaccinated.

Cox of Utah said competition between states at the onset of the epidemic, when the federal government forced states to shout for personal protective equipment such as supplies, should be avoided in the case of vaccines.

He said, “It shouldn’t be Hunger Games, as it was with PPE. It was ridiculous and we all had to play that game.” Cox said, “We’re all in this together. The governors are in this together. All we need is information from the federal government and the manufacturers.”

New administration, new reality

Biden’s coronovirus advisors have high hopes that the shortage can be avoided, Dr. Vivek Murthy, who is nominated for Surgeon General, called the mayors a webcast on Friday.

“We are confident of getting more supplies from our interactions with companies, and this will continue to grow over the next few months,” said Murthy.

There may be more vaccines soon and they could be a big boost to the rollout

Director of the National Institute of Allergy and Infectious Diseases, Drs. Anthony Fauci said he expected to receive positive news about Johnson & Johnson’s single dose coronavirus vaccine in the next few weeks.

“I don’t want to go beyond them, but I have to tell you that I would be surprised that it was more than two weeks from now that the data would be analyzed, and decisions would be made,” Fauci said on MSNBC.

Fauci spoke with CNN on Friday. The coronovirus variant, known as B.1.1.7, was first identified in the United Kingdom and is believed to be more contagious. He says that its broadcast in the US needs to be carefully monitored.
Emerging evidence suggests that new coronavirus versions may be problematic for vaccines

According to the CDC, at least 195 cases of the variant have been identified in 22 states. The number does not represent the total number of cases in the US, the agency said, but only those that have been found through analysis.

“It hasn’t dominated,” Fauci said. “It can be. That’s why you have to watch it carefully as we go from January to February, and take a really good look.”

A CDC report this month noted that this variant has the potential to “increase America’s epidemic in the coming months” and focus on other measures that make people use masks, maintain social distance, and reduce transmission Should give.

Fauci agreed with the health recommendations. “It’s the kind of thing that prevents serges … the type of virus.”

The report contributed to CNN’s Maggie Fox, Madeline Holcombe, Lauren Mascarenhas, Raja Rezek, Chuck Johnson, Holly Silverman, Amanda Watts, Nick Neville, Andrea Diaz, Naomi Thomas, Michael Nedelman, and Alta Spulse.


Leave a Reply

Your email address will not be published.